ZPDH:XETRA:XETRA-SPDR S&P U.S. Health Care Select Sector UCITS (EUR)

ETF | Others |

Last Closing

USD 41.33

Change

+0.32 (+0.77)%

Market Cap

USD 0.36B

Volume

897.00

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-03-28 )

ETFs Containing ZPDH:XETRA

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 11.34% 81% B- 79% B-
Dividend Return N/A N/A N/A N/A N/A
Total Return 11.34% 81% B- 79% B-
Trailing 12 Months  
Capital Gain 18.56% 66% D+ 69% C-
Dividend Return N/A N/A N/A N/A N/A
Total Return 18.56% 66% D+ 68% D+
Trailing 5 Years  
Capital Gain 80.68% 86% B+ 83% B
Dividend Return N/A N/A N/A N/A N/A
Total Return 80.68% 86% B+ 82% B
Average Annual (5 Year Horizon)  
Capital Gain 11.96% 86% B+ 82% B
Dividend Return 11.96% 85% B 80% B-
Total Return N/A 96% N/A 98% N/A
Risk Return Profile  
Volatility (Standard Deviation) 11.03% 57% F 66% D+
Risk Adjusted Return 108.43% 100% F 99% N/A
Market Capitalization 0.36B 62% D 55% F

Annual Financials (EUR)

Quarterly Financials (EUR)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior risk adjusted returns

This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.

Superior total returns

The stock has outperformed its sector peers on average annual total returns basis in the past 5 years (for a hold period of at least 12 months) and is in the top quartile.

What to not like:

There is nothing we particularly dislike